November 26th, 2025: Ozempic and Mounjaro Litigation Expands Following New Evidence of Heightened GI Risks A newly released study has increased scrutiny of GLP-1 receptor agonists such as Ozempic, Mounjaro, and Trulicity, linking these medications to substantially higher rates of gastrointestinal complications than older diabetes treatments
Delivery is included as part of the complete service, so you never have to worry about picking up your medication
Zemonova Injectable GLP-1 + GIP Tirzapatide Once-weekly injection with powerful appetite control Dual-action GLP-1 + GIP therapy for maximum weight loss Compounded with Personalized ingredients to help you feel your best
doi: 10.1016/S1474-4422(24)00430-7 [PubMed] 41260851 Siegel CR, Khoujah D
While it's not a magic solution, Mounjaro represents a promising advancement in the treatment of these chronic conditions, offering hope to millions of people worldwide seeking better health outcomes and improved quality of life.